Experimental models of dermal fibrosis and systemic sclerosis

被引:13
|
作者
Avouac, Jerome [1 ]
Elhai, Muriel [1 ]
Allanore, Yannick [1 ]
机构
[1] Paris Descartes Univ, Cochin Hosp, Rheumatol Dept A, INSERM,U1016,CNRS,UMR8104,Cochin Inst, Paris, France
关键词
Systemic sclerosis; Animal models; Dermal fibrosis; VERSUS-HOST-DISEASE; MAST-CELL DEPLETION; LUNG FIBROSIS; MURINE MODEL; T-CELLS; SCLERODERMA; SKIN; DNA; ACTIVATION; RECEPTOR;
D O I
10.1016/j.jbspin.2012.06.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasculopathy, immunological abnormalities, and fibrosis are the key features in the pathogenesis of systemic sclerosis (SSc). Expression of each of the three pathologic features varies among SSc patients leading to disease heterogeneity and variable organ manifestations. Although the etiology of SSc has not yet been fully elucidated, a growing body of evidence suggests that extracellular matrix overproduction by activated fibroblasts results from a complex interplay between endothelial cells, immune cells and fibroblasts through cell cell and cell matrix interactions and communications. Relevant animal models are essential tools to in-depth investigate pathogenesis of SSc. Several murine and avian models are available; however, some models display inflammation followed by fibrosis, whether some others primarily mimic autonomous fibroblast activation. In addition, typical microvascular changes of SSc are only observed in few models. Therefore, none of these animal models encompasses all features of the human disease and a critical selection is mandatory for successful in vivo studies. Hence, we will provide an overview of the most important experimental models of dermal fibrosis and SSc and discuss their respective contribution to the better understanding of SSc pathogenesis. (c) 2012 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [1] Neuropeptide Cortistatin Regulates Dermal and Pulmonary Fibrosis in an Experimental Model of Systemic Sclerosis
    Barriga, Margarita
    Benitez, Raquel
    Robledo, Gema
    Caro, Marta
    O'Valle, Francisco
    Campos-Salinas, Jenny
    Delgado, Mario
    NEUROENDOCRINOLOGY, 2022, 112 (08) : 784 - 795
  • [2] Osteopontin in Systemic Sclerosis and Its Role in Dermal Fibrosis
    Wu, Minghua
    Schneider, Daniel J.
    Mayes, Maureen D.
    Assassi, Shervin
    Arnett, Frank C.
    Tan, Filemon K.
    Blackburn, Michael R.
    Agarwal, Sandeep K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (06) : 1605 - 1614
  • [3] Osteopontin in systemic sclerosis and its role in dermal fibrosis
    Wu, Minghua
    Schneider, Daniel J.
    Mayes, Maureen D.
    Assassi, Shervin
    Arnett, Frank C.
    Tan, Filemon K.
    Blackburn, Michael R.
    Agarwal, Sandeep K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S81 - S81
  • [4] The Role of Adiponectin in the Pathogenesis of Dermal Fibrosis in Systemic Sclerosis
    Asano, Yoshihide
    Masui, Yuri
    Kadono, Takafumi
    Sato, Shinichi
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S906 - S906
  • [5] Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis
    Speca, Silvia
    Farhat, Meryem-Maud
    Jendoubi, Manel
    Guerrier, Thomas
    Sanges, Sebastien
    Staumont-Salle, Delphine
    Hachulla, Eric
    Dubucquoi, Sylvain
    Sobanski, Vincent
    Collet, Aurore
    Launay, David
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis
    Silvia Speca
    Meryem-Maud Farhat
    Manel Jendoubi
    Thomas Guerrier
    Sébastien Sanges
    Delphine Staumont-Sallé
    Eric Hachulla
    Sylvain Dubucquoi
    Vincent Sobanski
    Aurore Collet
    David Launay
    Scientific Reports, 13
  • [7] TREATMENT WITH ABATACEPT PREVENTS EXPERIMENTAL DERMAL FIBROSIS AND INDUCES REGRESSION OF ESTABLISHED FIBROSIS IN A PRECLINICAL MODEL OF SYSTEMIC SCLEROSIS
    Ponsoye, M.
    Frantz, C.
    Ruzehaji, N.
    Elhai, M.
    Ruiz, B.
    Cauvet, A.
    Allanore, Y.
    Avouac, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 585 - 586
  • [8] Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc)
    Huang, Jingang
    Beyer, Christian
    Palumbo-Zerr, Katrin
    Zhang, Yun
    Wollin, Stefan-Lutz
    Distler, Joerg
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [9] Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis
    Jiang, Ying
    Hu, Feifei
    Li, Ming
    Li, Qiao
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2024, 51 (02)
  • [10] Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis
    Higuchi, Tomoaki
    Kawaguchi, Yasushi
    Takagi, Kae
    Tochimoto, Akiko
    Ichimnura, Yuki
    Katsumata, Yasuhiro
    Ichida, Hisae
    Kawasumi, Hidenaga
    Nishina, Hirokazu
    Tochihara, Mari
    Nishino, Akira
    Hirahara, Shinya
    Moriyama, Rina
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2016, 68